Top Markets
Coin of the day
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Hisse Senetlerindeki Sıralama #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Hisse Fiyatı
$1.81
Son senkronizasyon: 2026-08-21
Piyasa Değeri
$77.00M
Değişim (1 gün)
1.30%
Değişim (1 yıl)
-23.63%
Ülke
US
Ticaret Annovis Bio, Inc. (ANVS)

Kategori

Annovis Bio, Inc. (ANVS) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $1.82 - 2026-08-01

Gün sonu en düşük fiyat: $7.71 - 2020-01-01
Annovis Bio, Inc. için hisse fiyatı geçmişi: 2020 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -38.81%
2025 -26.28%
2024 -55.51%
2023 0.70%
2022 -41.39%
2021 233.32%
2020 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH